ANI Pharmaceuticals, Inc.
NASDAQ:ANIP · NASDAQ Global Market
-$1.42 today
Vol 0.32M · Avg 0.35M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+20.38%
Period High
$98.81
Period Low
$63.35
Latest
$79.49
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Hisamitsu Pharmaceutical Co., Inc.
HTSUF
$2.04B
Dermapharm Holding SE
DMPHF
$1.96B
Fagron N.V.
ARSUF
$1.95B
Trulieve Cannabis Corp.
TCNNF
$1.82B
Green Thumb Industries Inc.
GTBIF
$1.74B
Tsumura & Co.
TSMRF
$1.73B
Harrow Health, Inc.
NASDAQ:HROW
$1.57B
CanSino Biologics Inc.
CASBF
$999.02M
Tilray Brands, Inc.
NASDAQ:TLRY
$560.26M
BGM Group Ltd.
NASDAQ:BGM
$79.13M
What is the latest ANIP filing?
The latest filing shown is 4 dated Jun 15, 2026.
How many recent filings does ANIP have?
Intrinsic Alpha currently shows 20 recent filings for ANIP.
Explore More
Continue the stock analysis
Jump to another research area for this company.